Acceder

Threshold Pharmaceuticals, Inc (THLD): Opiniones

12,3K respuestas
Threshold Pharmaceuticals, Inc (THLD): Opiniones
2 suscriptores
Threshold Pharmaceuticals, Inc (THLD): Opiniones
Página
966 / 1.539
#7721

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

THLD
Datos actualizados Fase II SARCOMA

http://www.equities.com/news/headline-story?dt=2012-11-15&val=717465&cat=hcare

a estudiar señores, a estudarlos!

"We are pleased with these results suggesting that TH-302 can be combined with doxorubicin and continued as single agent maintenance treatment for patients with soft tissue sarcoma," said Tillman Pearce, M.D., Chief Medical Officer of Threshold. "These results support our ongoing Phase 3 clinical trial evaluating the potential efficacy and safety of TH-302 plus doxorubicin in extending the lives of patients with soft tissue sarcoma."

TH-302 has been granted Orphan Drug Designation in the U.S. and Europe for the treatment of soft tissue sarcoma.

#7722

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

Stop! Nuevos resultados del TH-302 y Doxorubicin en tejidos blandos (Sarcoma)

http://investor.thresholdpharm.com/releasedetail.cfm?ReleaseID=721505

De todo me quedo con esto:
"We are pleased with these results suggesting that TH-302 can be combined with doxorubicin and continued as single agent maintenance treatment for patients with soft tissue sarcoma," said Tillman Pearce, M.D., Chief Medical Officer of Threshold. "These results support our ongoing Phase 3 clinical trial evaluating the potential efficacy and safety of TH-302 plus doxorubicin in extending the lives of patients with soft tissue sarcoma."

A ver si es suficiente para detener la sangría y que vuelva el interés comprador a THLD

#7724

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

http://www.nasdaq.com/symbol/thld/premarket
4.40
Volumen: Yo solo llevo más acciones y soy un matao.
Seamos realistas !

#7725

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

Asi es @framus, pero eso no era ya conocido? ¿o solo era en USA?

TH-302 has been granted Orphan Drug Designation in the U.S. and Europe for the treatment of soft tissue sarcoma

#7727

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

Aquí en su web está como siempre la conferencia de ayer entera

http://investor.thresholdpharm.com/events.cfm